Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04783155 · ClinicalTrials.gov registry record · NA
Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant
A NA study of Post-Lung Transplantation Bronchiectasis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04783155: Recruiting NA study of Post-Lung Transplantation Bronchiectasis, sponsored by Mayo Clinic.
NCT04783155 is a NA study of Post-Lung Transplantation Bronchiectasis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04783155, a NA study of Post-Lung Transplantation Bronchiectasis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study the effect of training the inspiratory muscles (i.e. the muscle that allow you to breath-in) on exercise capacity, quality of life, and short-term clinical outcomes in patients post lung transplant.
Primary Outcome
The maximal strength generating capacity of the inspiratory muscles.
Conditions Studied
Interventions
- DEVICE POWERBreathe Plus®
- OTHER Cardiopulmonary rehabilitation post lung transplant
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT04783155 shows while recruiting
NCT04783155 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Post-Lung Transplantation Bronchiectasis appearing as the primary indexed condition, and to 2 interventions - of which POWERBreathe Plus® is the first listed.
NCT04783155 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04783155 about?
NCT04783155 is a clinical study titled "Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant". The purpose of this research is to study the effect of training the inspiratory muscles (i.e. the muscle that allow you to breath-in) on exercise capacity, quality of life, and short-term clinical outcomes in patients post lung transplant.
What is the current status of trial NCT04783155?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-10. Estimated completion is 2027-12.
What conditions does trial NCT04783155 study?
This clinical trial studies the following conditions: Post-Lung Transplantation Bronchiectasis.
What interventions are being tested in trial NCT04783155?
The interventions under investigation include: POWERBreathe Plus® (DEVICE), Cardiopulmonary rehabilitation post lung transplant (OTHER).
Who is sponsoring clinical trial NCT04783155?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04783155 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Lung Transplantation Bronchiectasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04783155's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI